Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. | Life Sci;30(10): 827-32, 1982 Mar 08. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease.

Growdon, J H; Melamed, E; Logue, M; Hefti, F; Wurtman, R J.

Life Sci ; 30(10): 827-32, 1982 Mar 08.

Article in En | MEDLINE | ID: mdl-6175872

Subject(s)

Homovanillic Acid/cerebrospinal fluid; Parkinson Disease/cerebrospinal fluid; Phenylacetates/cerebrospinal fluid; Tyrosine/cerebrospinal fluid; Administration, Oral; Chromatography, High Pressure Liquid; Humans; Hydroxyindoleacetic Acid/cerebrospinal fluid; Probenecid/cerebrospinal fluid; Tyrosine/administration & dosage

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Phenylacetates / Tyrosine / Homovanillic Acid Limits: Humans Language: En Journal: Life Sci Year: 1982 Document type: Article Country of publication: Netherlands

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Phenylacetates / Tyrosine / Homovanillic Acid Limits: Humans Language: En Journal: Life Sci Year: 1982 Document type: Article Country of publication: Netherlands